Navigation Links
Lilly Caps Successful Year with Strong Fourth-Quarter Results
Date:1/29/2008

- Q4 reported results include 22 percent sales growth and EPS of $.78 - Q4 pro forma adjusted results include 16 percent sales growth and EPS of

$.90 - Full-year results highlighted by double-digit growth in both sales and

EPS

INDIANAPOLIS, Jan. 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced financial results for the fourth quarter and full year of 2007.

Throughout this release, financial results are presented on both a reported and a pro forma adjusted basis. Reported results were prepared in accordance with generally accepted accounting principles (GAAP) and include all sales and expenses recognized by the company during the period. Pro forma adjusted results exclude items described in the reconciliation tables below and also assume the ICOS acquisition was completed January 1, 2006. The pro forma adjusted results are presented in order to provide additional insights into the underlying trends in the business. Financial guidance is also provided on both a reported and a pro forma adjusted basis.

Fourth-Quarter Highlights - Reported Results

-- Sales increased 22 percent, to $5.190 billion.

-- Products launched this decade -- Alimta(R), Byetta(R), Cialis(R),

Cymbalta(R), Forteo(R), Strattera(R), Symbyax(R), Xigris(R) and

Yentreve(R) -- collectively grew 55 percent, to $1.7 billion, and

accounted for 33 percent of total sales, compared with 26 percent of

total sales in the fourth quarter of 2006.

-- Net income and earnings per share grew to $854.4 million and $.78,

respectively, compared with fourth-quarter 2006 net income of $132.3'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine news :

1. Lilly Sets Date and Conference Call for Fourth Quarter and Full Year 2007 Financial Results Announcement
2. Lilly Announces Dividend Increase
3. Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
4. International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
5. JDRF and Lilly partner to fund research to identify beta cell biomarkers
6. The Lilly MDR-TB Partnership Provides Unique Model for Fight Against Multidrug-Resistant Tuberculosis in South Africa
7. Lilly Contributes $10.8 Million to United Way Annual Campaign
8. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
9. Lilly Sets Date and Time for American Heart Association Conference Call
10. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
11. Eli Lilly and Company Aids California Recovery Effort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 “ Logical Operations ... monthly Tech Report, which takes a look at the ... consumers. Mallory Sofastaii, a special reporter for NewsWatch and ... viewers how this company helps companies avoid cyber security ... news, they’ll probably see cyber security somewhere in the ...
(Date:2/27/2015)... 27, 2015 Mirena IUD lawsuits ( ... allegedly suffered uterine perforations and other serious harm due ... to move forward in the multicounty litigation underway in ... reports. Court records indicate that the proceeding’s 34th ... a Conference convened that same day. (In Re: Mirena ...
(Date:2/27/2015)... February 27, 2015 Jupiter Medical Center ... partnership, Mount Sinai Heart New York at Jupiter Medical ... in South Florida. , “This innovative collaboration with ... we’re delivering unparalleled health care in our very own ... Officer of Jupiter Medical Center. “This kind of innovative ...
(Date:2/27/2015)... Lyophilization has important applications in the pharmaceutical and biotechnology ... stabilize, store and increase the shelf life of drug ... antibodies, proteins, enzymes, hormones, blood plasma and bacteria-derived compounds ... market was valued at $1,969.7 million in 2014 and ... at a CAGR of 6.2% during the forecast period. ...
(Date:2/27/2015)... DiabetesSisters, a national 501c3 nonprofit ... by women with diabetes, is proud to announce ... aims to develop the skills of 24 carefully ... weekend of April 24-26th in Raleigh, NC. ... participants was made based on the applicant’s demonstrated ...
Breaking Medicine News(10 mins):Health News:A Way for Companies to Avoid Cyber Security Threats was Featured on NewsWatch Television on January 30, 2015 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Progress in New Jersey with Issuance of New Case Management Order, Bernstein Liebhard LLP Reports 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 2Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 3Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 4Health News:Jupiter Medical Center and Mount Sinai Heart New York Announce Landmark Partnership 5Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Lyophilization Equipment Market worth $2,655.9 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:DiabetesSisters Announces 2015 Leadership Institute for April 24-26, 2015 2
... respiratory trouble, researchers note , THURSDAY, Oct. 4 ... at Children,s Hospital Boston have found new information ... (BPD), a lung disease that affects premature newborns ... prevent or treat BPD, which can cause long-term ...
... BETHESDA, Md., Oct. 4 New research from ... colonography,published in the New England Journal of Medicine ... colorectal cancer screening using a,CT scan of the ... and to advancing new frontiers in medicine.,While all ...
... for Geriatric Nursing Excellence in the University of Iowa ... the nation, have been funded for a four-year $1.2 ... recent evidence-based guidelines for caring for elders with mental ... Nursing Excellence, which will form the Geropsychiatric Nursing Collaborative, ...
... BENSALEM, Pa., Oct. 4 Law Offices of Howard ... been filed on behalf,of shareholders who purchased the common ... MEND ) between February 12,2007 and September 17, 2007, ... in the United States District Court for the,Southern District ...
... potentially fatal tick-borne illness has nearly tripled, research shows , ... Mountain spotted fever in the United States almost tripled from ... The potentially fatal disease is caused by Rickettsia rickettsii ... of the dog tick or Rocky Mountain wood tick. Within ...
... YORK, October 4, 2007 The Board of,Directors of ... dividends of $.36 per common share, payable on November ... The Company has paid,uninterrupted dividends on its common stock ... Colgate-Palmolive is a leading global consumer,products company, tightly focused ...
Cached Medicine News:Health News:Genes Give Clues to Newborn Lung Disease 2Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 2Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 3Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 4Health News:Surge in U.S. Cases of Rocky Mountain Spotted Fever 2
(Date:2/26/2015)... 26, 2015  AbbVie (NYSE: ABBV ... in its neuroscience and oncology development programs have ... American Academy of Neurology annual meeting in ... 18-25. The accepted abstracts feature results from studies ... investigational treatments in AbbVie,s pipeline. Presentations will include ...
(Date:2/26/2015)... Feb. 26, 2015  Mobility Ventures LLC, an AM ... Bank of America (NYSE: BAC ) that ... financing of the revolutionary MV-1 - - the world,s ... ground up to provide safe and comfortable transportation for ... their loan to purchase a new MV-1 vehicle at ...
(Date:2/26/2015)... -- Every year many millions of donations are obtained ... year after year doctors and the medical profession continue ... to determine the status of heart health in all ... though that technology is over 100 years old, ... (while most patients do not know) that EKG,s, in ...
Breaking Medicine Technology:AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3National Heart Health Month In February 2
... LLC announced today that it has achieved the ... Products Certification for Health Information Line. The accreditation ... nurseline staffed by highly experienced, registered nurses that ... providing immediate clinical support for everyday health issues ...
... England, April 6, 2011 BioWa, Inc. (BioWa) ... they have entered into a license agreement to ... Technology platform for the development of antibody dependent ... OBT intends to use POTELLIGENT® Technology to develop, ...
Cached Medicine Technology:Alere Earns NCQA Health Information Products Certification for Health Information Line 2Oxford BioTherapeutics Licenses BioWa's POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer 2Oxford BioTherapeutics Licenses BioWa's POTELLIGENT® Technology for the Research and Development of its Therapeutic Antibodies in Cancer 3
LifeStent FlexStar delivery systems offer clinicians multiple methods for stent deployment to accommodate individual preference....
... Tendril ST leads ... pacing leads, designed to ... reliability and flexibility to ... These pre-formed "J leads ...
RV Tracking for 100 % Resynchronization...
O-arm combines the best features of a traditional c-arm with an intra-operative 3D scannerfor unparalleled surgical imaging....
Medicine Products: